24/7 Patient Assistance: 760-405-8205

John Barton, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Education & Training


    Wake Forest

    Medical School


    Wake Forest University



    Wake Forest University


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Saint Thomas - Rutherford Hospital

    Languages: English/Spanish

    (615) 396-4100

    1700 Medical Center Pkwy

    Murfreesboro, Tennessee 37129

    Read More
  • Publications & Memberships

    Dr. John Barton has contributed to 3 publications.

    A phase I dose escalation study of NK012, an SN-38 incorporating macromolecular polymeric micelle.

    Burris, H. A.,Infante, J. R.,Anthony Greco, F.,Thompson, D. S.,Barton, J. H.,Bendell, J. C.,Nambu, Y.,Watanabe, N.,Jones, S. F.; Cancer Chemother. Pharmacol.. 1900 Jan 01.

    See more >>

    A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory m...

    Bendell, J. C.,Jones, S. F.,Hart, L.,Spigel, D. R.,Lane, C. M.,Earwood, C.,Infante, J. R.,Barton, J.,Burris, H. A.; Invest New Drugs. 2014 Oct 23.

    See more >>

    22 citations Hormonal therapy plus bevacizumab in postmenopausal patients who have hormone receptor-positive metastatic breast cancer: a phase II Trial of the Sarah Cannon Oncology...

    Yardley DA, Burris HA, Clark BL, Shipley D, Rubin M, Barton J, Arrowsmith E, Hainsworth JD; Clin. Breast Cancer. 2011-06-01.

    See more >>